Analysts at Sidoti Csr cut their Q3 2025 earnings estimates for Lifetime Brands in a research report issued on Friday, March ...
HC Wainwright reissued their buy rating on shares of Atyr PHARMA (NASDAQ:ATYR – Free Report) in a research note published on Friday morning,Benzinga reports. They currently have a $35.00 price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results